“…It was first described by Keech and Creech (1997) as a T-cell lymphoma in proximity to a saline-filled breast implant. The cells were reported to be CD2, CD4, CD30, and CD56 positive and negative for CD7, CD8, TCL1, EBER (Epstein–Barr coding region), and ALK (anaplastic lymphoma kinase) (Srinivasa et al ., 2017; Perry et al ., 2022). In 2016, the WHO admitted BIA-ALCL as a possible long-term complication of breast implants (Swerdlow et al ., 2016), and in 2017, this variant p T-cell lymphoma was included in the classification of lymphoid neoplasms.…”